| Composition | Rosuvastatin 10mg Clopidogrel 75mg |
|---|---|
| Dosage | CAPSULE |
| Packing Size | 10×15 |
| Packing | Strip |
ROZVIN CV 10/75 is a dual-action cardiovascular therapy that combines Rosuvastatin 10 mg, a potent lipid-lowering statin, with Clopidogrel 75 mg, an antiplatelet agent. This combination is formulated to manage cholesterol levels while reducing platelet aggregation, providing comprehensive protection against cardiovascular events such as heart attack, stroke, and atherosclerosis in at-risk patients.
By targeting both dyslipidemia and thrombotic risk, ROZVIN CV 10/75 ensures enhanced heart protection in a single convenient tablet.
Each tablet contains:
Rosuvastatin 10 mg – HMG-CoA reductase inhibitor that lowers LDL cholesterol, total cholesterol, and triglycerides while increasing HDL cholesterol.
Clopidogrel 75 mg – Antiplatelet agent that inhibits platelet aggregation, reducing the risk of thrombotic cardiovascular events.
(Excipients q.s., as per approved formulation.)
Tablet
Lipid-Lowering & Antiplatelet Therapy / Cardiovascular Protection
ROZVIN CV 10/75 Tablets are indicated for:
Patients with hypercholesterolemia or mixed dyslipidemia at high cardiovascular risk
Prevention of heart attack, stroke, or other thrombotic events
Secondary prevention in patients with previous myocardial infarction, coronary artery disease, or stent placement
Patients requiring cholesterol management combined with antiplatelet therapy
Rosuvastatin inhibits the HMG-CoA reductase enzyme, reducing cholesterol synthesis in the liver and improving the lipid profile.
Clopidogrel blocks platelet activation and aggregation, preventing thrombus formation and lowering the risk of cardiovascular events.
The combination addresses cholesterol control and blood clot prevention simultaneously, providing effective dual cardiovascular protection.
Recommended Dose: As prescribed by the physician, usually once daily
Route: Oral
Duration: Long-term therapy as advised by a healthcare provider
Note: Regular monitoring of lipid profile, liver function, and bleeding risk is recommended during therapy.
Reduces LDL cholesterol and triglycerides
Increases HDL cholesterol
Prevents platelet aggregation and thrombus formation
Reduces risk of heart attack, stroke, and atherosclerosis
Convenient once-daily tablet improves patient compliance
ROZVIN CV 10/75 is generally well tolerated. Possible side effects include:
Mild gastrointestinal discomfort (nausea, abdominal pain)
Headache or dizziness
Muscle pain or weakness (rare, associated with statins)
Increased bleeding risk due to Clopidogrel
Patients should consult their physician if side effects persist or worsen.
Avoid in patients with active bleeding disorders or history of hemorrhagic stroke
Use with caution in liver or kidney impairment
Not recommended during pregnancy or lactation
Inform your doctor about other medications to prevent interactions
Regular monitoring of liver enzymes, lipid profile, and bleeding risk is advised
Store below 25°C, in a dry place away from sunlight. Keep out of reach of children.
Brand Name: ROZVIN CV 10/75
Composition: Rosuvastatin 10 mg + Clopidogrel 75 mg
Dosage Form: Tablet
Therapeutic Class: Lipid-Lowering & Antiplatelet / Cardiovascular Protection
Manufacturer: [Insert Company Name]
Packaging: [Example: 10×10 Tablets / Strip]
Combines cholesterol management with antiplatelet therapy in a single tablet
Provides dual cardiovascular protection for high-risk patients
Convenient once-daily dosing enhances adherence
Manufactured under GMP-certified quality standards
ROZVIN CV 10/75 (Rosuvastatin 10 mg + Clopidogrel 75 mg Tablets) offers comprehensive cardiovascular protection by managing cholesterol and preventing platelet aggregation. This dual-action therapy helps reduce the risk of heart attack, stroke, and atherosclerosis, supporting long-term heart health and overall cardiovascular wellness.
